These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

168 related articles for article (PubMed ID: 38816706)

  • 1. Placental growth factor promotes neural invasion and predicts disease prognosis in resectable pancreatic cancer.
    Göhrig A; Hilfenhaus G; Rosseck F; Welzel M; Moser B; Barbone G; Kunze CA; Rein J; Wilken G; Böhmig M; Malinka T; Tacke F; Bahra M; Detjen KM; Fischer C
    J Exp Clin Cancer Res; 2024 May; 43(1):153. PubMed ID: 38816706
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Tenascin C in the Tumor-Nerve Microenvironment Enhances Perineural Invasion and Correlates With Locoregional Recurrence in Pancreatic Ductal Adenocarcinoma.
    Furuhashi S; Sakaguchi T; Murakami T; Fukushima M; Morita Y; Ikegami K; Kikuchi H; Setou M; Takeuchi H
    Pancreas; 2020 Mar; 49(3):442-454. PubMed ID: 32132519
    [TBL] [Abstract][Full Text] [Related]  

  • 3. MUC4-promoted neural invasion is mediated by the axon guidance factor Netrin-1 in PDAC.
    Wang L; Zhi X; Zhu Y; Zhang Q; Wang W; Li Z; Tang J; Wang J; Wei S; Li B; Zhou J; Jiang J; Yang L; Xu H; Xu Z
    Oncotarget; 2015 Oct; 6(32):33805-22. PubMed ID: 26393880
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Levels of elevated circulating endothelial cell decline after tumor resection in patients with pancreatic ductal adenocarcinoma.
    Sabbaghian MS; Rothberger G; Alongi AP; Gagner JP; Goldberg JD; Rolnitzky L; Chiriboga L; Hajdu CH; Zagzag D; Basch R; Shamamian P
    Anticancer Res; 2010 Jul; 30(7):2911-7. PubMed ID: 20683032
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Aspartate β-hydroxylase promotes pancreatic ductal adenocarcinoma metastasis through activation of SRC signaling pathway.
    Ogawa K; Lin Q; Li L; Bai X; Chen X; Chen H; Kong R; Wang Y; Zhu H; He F; Xu Q; Liu L; Li M; Zhang S; Nagaoka K; Carlson R; Safran H; Charpentier K; Sun B; Wands J; Dong X
    J Hematol Oncol; 2019 Dec; 12(1):144. PubMed ID: 31888763
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Biomarker panel predicts survival after resection in pancreatic ductal adenocarcinoma: A multi-institutional cohort study.
    Nahm CB; Turchini J; Jamieson N; Moon E; Sioson L; Itchins M; Arena J; Colvin E; Howell VM; Pavlakis N; Clarke S; Samra JS; Gill AJ; Mittal A
    Eur J Surg Oncol; 2019 Feb; 45(2):218-224. PubMed ID: 30348604
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Preoperative risk factors for early recurrence in patients with resectable pancreatic ductal adenocarcinoma after curative intent surgical resection.
    Kim NH; Kim HJ
    Hepatobiliary Pancreat Dis Int; 2018 Oct; 17(5):450-455. PubMed ID: 30237091
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Perineural and intraneural invasion in posttherapy pancreaticoduodenectomy specimens predicts poor prognosis in patients with pancreatic ductal adenocarcinoma.
    Chatterjee D; Katz MH; Rashid A; Wang H; Iuga AC; Varadhachary GR; Wolff RA; Lee JE; Pisters PW; Crane CH; Gomez HF; Abbruzzese JL; Fleming JB; Wang H
    Am J Surg Pathol; 2012 Mar; 36(3):409-17. PubMed ID: 22301497
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Axon guidance factor SLIT2 inhibits neural invasion and metastasis in pancreatic cancer.
    Göhrig A; Detjen KM; Hilfenhaus G; Körner JL; Welzel M; Arsenic R; Schmuck R; Bahra M; Wu JY; Wiedenmann B; Fischer C
    Cancer Res; 2014 Mar; 74(5):1529-40. PubMed ID: 24448236
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Tumor-neuroglia interaction promotes pancreatic cancer metastasis.
    Su D; Guo X; Huang L; Ye H; Li Z; Lin L; Chen R; Zhou Q
    Theranostics; 2020; 10(11):5029-5047. PubMed ID: 32308766
    [No Abstract]   [Full Text] [Related]  

  • 11. LIF Drives Neural Remodeling in Pancreatic Cancer and Offers a New Candidate Biomarker.
    Bressy C; Lac S; Nigri J; Leca J; Roques J; Lavaut MN; Secq V; Guillaumond F; Bui TT; Pietrasz D; Granjeaud S; Bachet JB; Ouaissi M; Iovanna J; Vasseur S; Tomasini R
    Cancer Res; 2018 Feb; 78(4):909-921. PubMed ID: 29269518
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Placental growth factor supports neuroendocrine tumor growth and predicts disease prognosis in patients.
    Hilfenhaus G; Göhrig A; Pape UF; Neumann T; Jann H; Zdunek D; Hess G; Stassen JM; Wiedenmann B; Detjen K; Pavel M; Fischer C
    Endocr Relat Cancer; 2013 Jun; 20(3):305-19. PubMed ID: 23463017
    [TBL] [Abstract][Full Text] [Related]  

  • 13. The influence of neural invasion on survival and tumor recurrence in pancreatic ductal adenocarcinoma - A systematic review and meta-analysis.
    Schorn S; Demir IE; Haller B; Scheufele F; Reyes CM; Tieftrunk E; Sargut M; Goess R; Friess H; Ceyhan GO
    Surg Oncol; 2017 Mar; 26(1):105-115. PubMed ID: 28317579
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Linc00675 is a novel marker of short survival and recurrence in patients with pancreatic ductal adenocarcinoma.
    Li DD; Fu ZQ; Lin Q; Zhou Y; Zhou QB; Li ZH; Tan LP; Chen RF; Liu YM
    World J Gastroenterol; 2015 Aug; 21(31):9348-57. PubMed ID: 26309360
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Expression of phosphorylated estrogen receptor beta is an independent negative prognostic factor for pancreatic ductal adenocarcinoma.
    Pozios I; Knösel T; Zhao Y; Assmann G; Pozios I; Müller MH; Bruns CJ; Kreis ME; Seeliger H
    J Cancer Res Clin Oncol; 2018 Oct; 144(10):1887-1897. PubMed ID: 30046904
    [TBL] [Abstract][Full Text] [Related]  

  • 16. High JAK2 Protein Expression Predicts a Poor Prognosis in Patients with Resectable Pancreatic Ductal Adenocarcinoma.
    Song Y; Tang MY; Chen W; Wang Z; Wang SL
    Dis Markers; 2020; 2020():7656031. PubMed ID: 33029256
    [TBL] [Abstract][Full Text] [Related]  

  • 17. LRG-1 promotes pancreatic cancer growth and metastasis via modulation of the EGFR/p38 signaling.
    Xie ZB; Zhang YF; Jin C; Mao YS; Fu DL
    J Exp Clin Cancer Res; 2019 Feb; 38(1):75. PubMed ID: 30760292
    [TBL] [Abstract][Full Text] [Related]  

  • 18. DEK protein overexpression predicts poor prognosis in pancreatic ductal adenocarcinoma.
    Sun J; Bi F; Yang Y; Zhang Y; Jin A; Li J; Lin Z
    Oncol Rep; 2017 Feb; 37(2):857-864. PubMed ID: 27959420
    [TBL] [Abstract][Full Text] [Related]  

  • 19. MicroRNA molecular profiles associated with diagnosis, clinicopathologic criteria, and overall survival in patients with resectable pancreatic ductal adenocarcinoma.
    Jamieson NB; Morran DC; Morton JP; Ali A; Dickson EJ; Carter CR; Sansom OJ; Evans TR; McKay CJ; Oien KA
    Clin Cancer Res; 2012 Jan; 18(2):534-45. PubMed ID: 22114136
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Activation of the IL-6R/Jak/stat pathway is associated with a poor outcome in resected pancreatic ductal adenocarcinoma.
    Denley SM; Jamieson NB; McCall P; Oien KA; Morton JP; Carter CR; Edwards J; McKay CJ
    J Gastrointest Surg; 2013 May; 17(5):887-98. PubMed ID: 23435739
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.